MeSH headings : Dogs; Animals; Lupus Erythematosus, Discoid / drug therapy; Lupus Erythematosus, Discoid / veterinary; Lupus Erythematosus, Cutaneous / drug therapy; Lupus Erythematosus, Cutaneous / veterinary; Lupus Erythematosus, Cutaneous / diagnosis; Pyrimidines; Sulfonamides; Dog Diseases / diagnosis

TL;DR: Oclacitinib may be considered an effective treatment option for different variants of canine CCLE variants due to their rapid inhibition of the action of interferons known to be relevant in the pathogenesis of CCLE. (via Semantic Scholar)